Comparing the current results to its competitors, Mettler Toledo International Inc reported Revenue increase in the 2 quarter 2026 by 4.48 % year on year. The revenue growth was below Mettler Toledo International Inc 's competitors' average revenue growth of 10.08 %, achieved in the same quarter.
Mettler toledo International Inc Net Income in the 2 quarter 2026 grew year on year by 15.1%, faster than the Mettler Toledo International Inc 's competitors average income growth of 13.74 %
Mettler Toledo International Inc 's Comment on Competition and Industry Peers
The company operates in highly competitive markets that are fragmented by geography and application, particularly in the industrial and food retail sectors. It faces numerous regional and specialized competitors, many of which are well established. Some competitors are divisions of larger companies with potentially greater financial and other resources. Additionally, certain competitors are based in emerging markets and may have lower cost structures. New competitors from emerging markets, while currently small, have the potential to grow in their home markets and become significant global competitors due to growth rates and cost advantages.
Overall company revenue, grew less, than total company revenues, at 4.48 % and company approximately market share, declined to 4.2 %. << More on MTD Market Share.
*Market share is calculated based on total revenue.
News about Mettler toledo International Inc Contracts
Publicly Traded Peers of Mettler toledo International Inc
Agilent Technologies inc Share Performance
+3.65%
This Year
Agilent Technologies inc
Profile
Agilent Technologies Inc. operates a business model centered on delivering innovative measurement solutions across industries like life sciences, diagnostics, and chemical analysis. Their revenue primarily comes from sales of instruments, software, and consumables, supplemented by support services. The company emphasizes strong partnerships and collaborations to enhance their market presence and influence.
10x Genomics Inc is a biotechnology company that specializes in providing tools and solutions for genomic research. Their business model revolves around developing innovative technologies and platforms to enable scientists and researchers to gain deeper insights into the structure and function of biological systems. They offer products such as single-cell sequencing and spatial transcriptomics to support various areas of genomics research and accelerate discoveries in fields like cancer research, immunology, and neuroscience.
Avantor Inc's business model revolves around providing a wide range of products, services, and solutions to customers in the life sciences, advanced technologies, and applied materials sectors. They focus on delivering a comprehensive offering, including chemicals, lab equipment, consumables, and customized solutions, to support research, development, and production processes.
Sources:
Mettler toledo International Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Mettler toledo International Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
